News
The Food and Drug Administration has approved updated COVID-19 vaccines for the upcoming fall and winter season ...
The pharmaceutical giant currently offers a 7% yield, but dividend investors need to look beyond the headline number.
Pfizer's diversified pipeline and new product launches are driving operational growth. Click here to read more about PFE ...
The biopharmaceutical company laid off 100 workers at its Bothell location on Monday, according to a notice filed with the ...
Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It will report its Q3 2025 earnings on Oct. 28. Wall Street analysts expect ...
Zacks.com on MSN3h
Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity?
Pfizer's strong Q2 results, high dividend yield, and bullish chart fuel optimism despite patent losses and rising competition ...
Olema Pharma's new Pfizer trial may spark a bidding war, says Oppenheimer. Learn what this means for HR+ breast cancer ...
Delving into the details, we found 62% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $308,528, and 4 were calls, valued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback